The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT(*D)
Last

(U.S.) $0.88

Today's change+0.01 +1.18%
Updated October 23 11:30 AM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT(*D)
Last

(U.S.) $0.88

Today's change+0.01 +1.18%
Updated October 23 11:30 AM -4GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc crosses above 50-day moving average

Neptune Technologies & Bioressources Inc is up today by (U.S.)$0.01 or 1.18% to (U.S.)$0.88 and crossing above its 50-day moving average. Over the last five days, shares have gained 4.45%, but are down 9.47% for the last year to date. Shares have underperformed the S&P 500 by 47.54% during the last year.

Key company metrics

  • Open(U.S.) $0.87
  • Previous close(U.S.) $0.87
  • High(U.S.) $0.88
  • Low(U.S.) $0.85
  • Bid / Ask(U.S.) $0.88 / (U.S.) $0.89
  • YTD % change-9.47%
  • Volume61,333
  • Average volume (10-day)68,044
  • Average volume (1-month)119,120
  • Average volume (3-month)165,848
  • 52-week range(U.S.) $0.70 to (U.S.) $1.25
  • Beta0.66
  • Trailing P/E11.13×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.10
Updated October 23 11:30 AM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.18%

Based on its net profit margin of 3.18%, Neptune Technologies & Bioressources Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.18%Sector:Industry:

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2018Q4/2017Q3/2017Q2/2017
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Nov 30, 201611/30/2016Aug 31, 201608/31/2016
Revenue7121212
Total other revenue--------
Total revenue7121212
Gross profit2333
Total cost of revenue4999
Total operating expense1011214
Selling / general / administrative4553
Research & development2--11
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total---2-130
Operating income-3110-2
Interest income (expense), net non-operating-1-----1
Gain (loss) on sale of assets--------
Other--------
Income before tax-309-2
Income after tax-3-29-2
Income tax, total0200
Net income-2011-1
Total adjustments to net income--------
Net income before extra. items-2011-1
Minority interest2211
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2011-1
Inc. avail. to common incl. extra. items-2011-1
Diluted net income-2011-1
Dilution adjustment--------
Diluted weighted average shares78787878
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.010.14-0.02
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.010.14-0.02